VOLITIONRX LTD — Form SCHEDULE 13D/A
Filed September 16, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 15/100
What the filing says
Lagoda Investment Management, L.P. filed an amended Schedule 13D/A regarding beneficial ownership in VolitionRx Ltd (market cap ~$72.9M). The filing is dated September 16, 2026, and amends a prior Schedule 13D. Specific ownership percentage, share count, acquisition details, and nature of the amendment are not disclosed in this filing header document.
Why this rating
Amendment filing alone, without disclosed stake details or transaction specifics, is routine disclosure. Cannot assess materiality without ownership % or transaction value.
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.